I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.
TVP1022, the S-enantiomer of rasagiline (Azilect®) (N-propargyl-1R-aminoindan), exerts cyto/cardio-protective effects in a variety of experimental cardiac and neuronal models. Previous studies have demonstrated that the protective activity of TVP1022 and other propargyl derivatives involve the activ...
Enregistré dans:
Auteurs principaux: | Yaron D Barac, Orit Bar-Am, Esti Liani, Tamar Amit, Luba Frolov, Elena Ovcharenko, Itzchak Angel, Moussa B H Youdim, Ofer Binah |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5f118b38e1ff4e3085d81f99839f6506 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Acta N°1022
par: Banco Central de Chile
Publié: (2021) -
QSPR STUDY OF CORROSION INHIBITORS. IMIDAZOLINES
par: VERA,LEONEL, et autres
Publié: (2006) -
The role of rasagiline in the treatment of Parkinson’s disease
par: Julie Leegwater-Kim, et autres
Publié: (2010) -
Rasagiline in treatment of Parkinson’s disease
par: Lakshmi Nayak, et autres
Publié: (2008) -
EFFECT OF GAMMA-IRRADIATION ON BIODEGRADABLE MICROSPHERES LOADED WITH RASAGILINE MESYLATE
par: FERNÁNDEZ,MARCOS, et autres
Publié: (2016)